HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleni Kampylafka Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

2/2024CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.
1/2019Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleni Kampylafka Research Topics

Disease

5Psoriatic Arthritis
10/2023 - 01/2018
4Inflammation (Inflammations)
02/2024 - 01/2018
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 01/2019
2Pain (Aches)
01/2020 - 01/2019
1Arthritis (Polyarthritis)
02/2024
1Experimental Arthritis
02/2024
1Joint Diseases (Joint Disease)
01/2019
1Synovitis
01/2018

Drug/Important Bio-Agent (IBA)

4Interleukin-17 (Interleukin 17)IBA
02/2024 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 01/2019
2secukinumabIBA
01/2020 - 01/2018
1Proteins (Proteins, Gene)FDA Link
02/2024
1RNA (Ribonucleic Acid)IBA
02/2024
1Circulating MicroRNAIBA
10/2023
1MicroRNAs (MicroRNA)IBA
10/2023
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1Antirheumatic Agents (DMARD)IBA
01/2019
1Ustekinumab (CNTO 1275)FDA Link
01/2019